US Stock MarketDetailed Quotes

ABVC ABVC BioPharma

Watchlist
  • 0.5488
  • -0.0011-0.20%
Close Nov 22 16:00 ET
  • 0.5340
  • -0.0148-2.70%
Post 20:02 ET
7.12MMarket Cap-677P/E (TTM)

ABVC BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
112.64%171.72K
-12.70%-1.01M
68.41%-473.16K
42.75%-4.24M
-3.99%-479.46K
-164.53%-1.36M
73.76%-899.83K
49.98%-1.5M
2.62%-7.4M
81.74%-461.07K
Net income from continuing operations
96.01%-134.27K
45.03%-1.27M
-109.83%-3.98M
33.12%-10.91M
26.02%-3.33M
10.82%-3.37M
-18.89%-2.32M
68.83%-1.9M
-35.53%-16.31M
34.78%-4.5M
Operating gains losses
--67.89K
----
----
--221.89K
----
----
----
----
----
----
Depreciation and amortization
-5.97%7.01K
90.15%13.31K
-80.19%1.29K
19.88%28.53K
17.82%7.58K
15.43%7.46K
27.43%7K
20.00%6.49K
98.44%23.8K
96.91%6.44K
Deferred tax
--0
----
----
-86.62%115.67K
-83.11%151.39K
-184.55%-117.41K
----
----
4.93%864.8K
-11.39%896.05K
Other non cash items
-83.19%218.48K
95.91%243.53K
44,282.51%672.02K
7,361.35%2.41M
55,408.62%991.38K
10,976.26%1.3M
1,232.60%124.31K
-116.01%-1.52K
108.96%32.35K
101.71%1.79K
Change In working capital
603.91%12.61K
-152.23%-490.04K
929.15%289.56K
26.47%803.8K
-111.38%-164.29K
-99.92%1.79K
157.23%938.16K
101.84%28.14K
139.38%635.57K
245.83%1.44M
-Change in receivables
-85.63%51.19K
-1,809.76%-378.25K
-5,459.45%-140.36K
93.58%-93.22K
-8.88%-474.24K
-75.07%356.28K
102.19%22.12K
100.18%2.62K
-102.67%-1.45M
54.96%-435.56K
-Change in prepaid assets
-74.52%6.93K
-70.33%60.63K
73.78%-53.38K
-57.19%101.93K
1,588.08%74K
-97.35%27.2K
130.43%204.34K
-79.73%-203.62K
166.64%238.09K
-101.72%-4.97K
-Change in payables and accrued expense
88.60%-43.51K
-127.64%-178.42K
110.92%483.31K
-61.49%712.88K
-88.38%219.95K
-274.82%-381.69K
1,436.53%645.48K
1,111.02%229.14K
460.48%1.85M
645.84%1.89M
-Change in other current liabilities
---2K
----
----
626.92%13.7K
715.38%16K
--0
----
----
---2.6K
---2.6K
-Change in other working capital
----
----
----
--68.52K
---1
--0
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
112.64%171.72K
-12.70%-1.01M
68.41%-473.16K
42.75%-4.24M
-3.99%-479.46K
-164.53%-1.36M
73.76%-899.83K
49.98%-1.5M
2.62%-7.4M
81.74%-461.07K
Investing cash flow
Cash flow from continuing investing activities
0
79.08%-360.19K
285.11%154.17K
95.16%-73.78K
-113.62%-1.72M
-119.51%-83.29K
Net PPE purchase and sale
----
----
----
82.29%-21.2K
--0
----
----
----
-583.84%-119.69K
---89
Net business purchase and sale
----
----
----
78.84%-338.99K
----
----
----
----
-135.27%-1.6M
----
Net investment purchase and sale
--0
----
----
----
----
96.54%-52.58K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
----
----
79.08%-360.19K
285.11%154.17K
95.16%-73.78K
----
----
-113.62%-1.72M
-119.51%-83.29K
Financing cash flow
Cash flow from continuing financing activities
-108.78%-145.39K
2,849.68%868.54K
-69.36%676.17K
-2.37%3.92M
134.49%87.42K
174.49%1.66M
-100.86%-31.59K
2.21M
-59.84%4.01M
-105.96%-253.5K
Net issuance payments of debt
90.17%-179.13K
--0
-87.22%282.1K
32.18%462.62K
--110.11K
-620.71%-1.82M
---31.59K
--2.21M
227.98%350K
--0
Net common stock issuance
-96.79%33.73K
----
----
-71.34%1.05M
--0
314.20%1.05M
----
----
-67.05%3.66M
-105.97%-253.5K
Proceeds from stock option exercised by employees
--0
--737.5K
--394.07K
--2.41M
---22.69K
--2.43M
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
-108.78%-145.39K
2,849.68%868.54K
-69.36%676.17K
-2.37%3.92M
134.49%87.42K
174.49%1.66M
-100.86%-31.59K
--2.21M
-59.84%4.01M
-105.96%-253.5K
Net cash flow
Beginning cash position
0.08%742.77K
-63.22%659K
-48.50%716.78K
-78.80%1.39M
-43.10%1.12M
-79.38%742.19K
-47.80%1.79M
-78.80%1.39M
31.27%6.57M
-55.72%1.97M
Current changes in cash
-88.24%26.33K
89.39%-145.56K
-71.37%203.01K
86.74%-677.07K
70.19%-237.87K
115.62%223.83K
-745.53%-1.37M
122.96%708.95K
-420.77%-5.11M
-137.02%-797.86K
Effect of exchange rate changes
-99.50%773
-28.85%229.32K
15.55%-260.78K
103.15%2.12K
-175.78%-166.29K
179.14%154.92K
802.48%322.3K
-583.95%-308.8K
-140.31%-67.34K
654.14%219.44K
End cash Position
-31.32%769.87K
0.08%742.77K
-63.22%659K
-48.50%716.78K
-48.50%716.78K
-43.10%1.12M
-79.38%742.19K
-47.80%1.79M
-78.80%1.39M
-78.80%1.39M
Free cash flow
112.44%171.72K
-12.70%-1.01M
68.41%-473.16K
43.38%-4.26M
-3.97%-479.46K
-166.40%-1.38M
73.93%-899.83K
51.49%-1.5M
1.28%-7.52M
81.73%-461.16K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 112.64%171.72K-12.70%-1.01M68.41%-473.16K42.75%-4.24M-3.99%-479.46K-164.53%-1.36M73.76%-899.83K49.98%-1.5M2.62%-7.4M81.74%-461.07K
Net income from continuing operations 96.01%-134.27K45.03%-1.27M-109.83%-3.98M33.12%-10.91M26.02%-3.33M10.82%-3.37M-18.89%-2.32M68.83%-1.9M-35.53%-16.31M34.78%-4.5M
Operating gains losses --67.89K----------221.89K------------------------
Depreciation and amortization -5.97%7.01K90.15%13.31K-80.19%1.29K19.88%28.53K17.82%7.58K15.43%7.46K27.43%7K20.00%6.49K98.44%23.8K96.91%6.44K
Deferred tax --0---------86.62%115.67K-83.11%151.39K-184.55%-117.41K--------4.93%864.8K-11.39%896.05K
Other non cash items -83.19%218.48K95.91%243.53K44,282.51%672.02K7,361.35%2.41M55,408.62%991.38K10,976.26%1.3M1,232.60%124.31K-116.01%-1.52K108.96%32.35K101.71%1.79K
Change In working capital 603.91%12.61K-152.23%-490.04K929.15%289.56K26.47%803.8K-111.38%-164.29K-99.92%1.79K157.23%938.16K101.84%28.14K139.38%635.57K245.83%1.44M
-Change in receivables -85.63%51.19K-1,809.76%-378.25K-5,459.45%-140.36K93.58%-93.22K-8.88%-474.24K-75.07%356.28K102.19%22.12K100.18%2.62K-102.67%-1.45M54.96%-435.56K
-Change in prepaid assets -74.52%6.93K-70.33%60.63K73.78%-53.38K-57.19%101.93K1,588.08%74K-97.35%27.2K130.43%204.34K-79.73%-203.62K166.64%238.09K-101.72%-4.97K
-Change in payables and accrued expense 88.60%-43.51K-127.64%-178.42K110.92%483.31K-61.49%712.88K-88.38%219.95K-274.82%-381.69K1,436.53%645.48K1,111.02%229.14K460.48%1.85M645.84%1.89M
-Change in other current liabilities ---2K--------626.92%13.7K715.38%16K--0-----------2.6K---2.6K
-Change in other working capital --------------68.52K---1--0----------------
Cash from discontinued investing activities
Operating cash flow 112.64%171.72K-12.70%-1.01M68.41%-473.16K42.75%-4.24M-3.99%-479.46K-164.53%-1.36M73.76%-899.83K49.98%-1.5M2.62%-7.4M81.74%-461.07K
Investing cash flow
Cash flow from continuing investing activities 079.08%-360.19K285.11%154.17K95.16%-73.78K-113.62%-1.72M-119.51%-83.29K
Net PPE purchase and sale ------------82.29%-21.2K--0-------------583.84%-119.69K---89
Net business purchase and sale ------------78.84%-338.99K-----------------135.27%-1.6M----
Net investment purchase and sale --0----------------96.54%-52.58K----------------
Cash from discontinued investing activities
Investing cash flow --0--------79.08%-360.19K285.11%154.17K95.16%-73.78K---------113.62%-1.72M-119.51%-83.29K
Financing cash flow
Cash flow from continuing financing activities -108.78%-145.39K2,849.68%868.54K-69.36%676.17K-2.37%3.92M134.49%87.42K174.49%1.66M-100.86%-31.59K2.21M-59.84%4.01M-105.96%-253.5K
Net issuance payments of debt 90.17%-179.13K--0-87.22%282.1K32.18%462.62K--110.11K-620.71%-1.82M---31.59K--2.21M227.98%350K--0
Net common stock issuance -96.79%33.73K---------71.34%1.05M--0314.20%1.05M---------67.05%3.66M-105.97%-253.5K
Proceeds from stock option exercised by employees --0--737.5K--394.07K--2.41M---22.69K--2.43M--0--0--0--0
Cash from discontinued financing activities
Financing cash flow -108.78%-145.39K2,849.68%868.54K-69.36%676.17K-2.37%3.92M134.49%87.42K174.49%1.66M-100.86%-31.59K--2.21M-59.84%4.01M-105.96%-253.5K
Net cash flow
Beginning cash position 0.08%742.77K-63.22%659K-48.50%716.78K-78.80%1.39M-43.10%1.12M-79.38%742.19K-47.80%1.79M-78.80%1.39M31.27%6.57M-55.72%1.97M
Current changes in cash -88.24%26.33K89.39%-145.56K-71.37%203.01K86.74%-677.07K70.19%-237.87K115.62%223.83K-745.53%-1.37M122.96%708.95K-420.77%-5.11M-137.02%-797.86K
Effect of exchange rate changes -99.50%773-28.85%229.32K15.55%-260.78K103.15%2.12K-175.78%-166.29K179.14%154.92K802.48%322.3K-583.95%-308.8K-140.31%-67.34K654.14%219.44K
End cash Position -31.32%769.87K0.08%742.77K-63.22%659K-48.50%716.78K-48.50%716.78K-43.10%1.12M-79.38%742.19K-47.80%1.79M-78.80%1.39M-78.80%1.39M
Free cash flow 112.44%171.72K-12.70%-1.01M68.41%-473.16K43.38%-4.26M-3.97%-479.46K-166.40%-1.38M73.93%-899.83K51.49%-1.5M1.28%-7.52M81.73%-461.16K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data